Treatment options in colchicine resistant familial Mediterranean fever patients : Thalidomide and etanercept as adjunctive agents

Regular colchicine treatment cannot control the typical febrile attacks of FMF in about 5-10% of the compliant patients. Here we report the effect of thalidomide and etanercept in 5 colchicine-resistant cases. Five (4M/ 1F) FMF patients between April 2005 and March 2006, who were experiencing at lea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental rheumatology 2006-09, Vol.24 (5), p.S99-103
Hauptverfasser:	SEYAHI, E, OZDOGAN, H, CELIK, S, UGURLU, S, YAZICI, H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Colchicine - pharmacology Diseases of the osteoarticular system Drug Resistance Drug Therapy, Combination Etanercept Familial Mediterranean Fever - drug therapy Female Humans Immunoglobulin G - therapeutic use Immunosuppressive Agents - therapeutic use Inflammatory joint diseases Male Malformations and congenital and or hereditary diseases involving bones. Joint deformations Medical sciences Pharmacology. Drug treatments Receptors, Tumor Necrosis Factor - therapeutic use Thalidomide - therapeutic use Tubulin Modulators - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!